Amelioration of LPS-induced inflammation response in microglia by AMPK activation

Chin-Chen Chen1, Jiun-Tsai Lin2, Yi-Fang Cheng2

  • 1Institute of Applied Science and Engineering, Catholic Fu-Jen University, New Taipei City 24205, Taiwan.

Insights

ENERGI-F704 from bamboo extract activates AMPK and reduces inflammation markers in microglia cells. This compound shows potential for treating neuroinflammatory diseases by modulating cellular energy and inflammatory pathways.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Adenosine 5'-monophosphate-activated protein kinase (AMPK) regulates cellular energy and inflammation.
  • Neuroinflammation is implicated in various neurological disorders.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of ENERGI-F704, a compound from bamboo shoot extract.
  • To determine if ENERGI-F704's anti-inflammatory activity is mediated through AMPK signaling.

Main Methods:

  • Treatment of microglia BV2 cells with ENERGI-F704.
  • Assay of AMPK phosphorylation (Thr-172).
  • Measurement of inflammatory markers (IL-6, TNF-α, NO, PGE2) and related protein expression (iNOS, COX-2, NF-κB).
  • Inhibition of AMPK using compound C.

Main Results:

  • ENERGI-F704 was nontoxic up to 80 μM and induced AMPK phosphorylation in BV2 cells.
  • ENERGI-F704 reduced LPS-induced IL-6 and TNF-α production.
  • ENERGI-F704 decreased nitric oxide and prostaglandin E2 production by downregulating iNOS and COX-2.
  • ENERGI-F704 inhibited NF-κB activation, an effect reversed by AMPK inhibition.

Conclusions:

  • ENERGI-F704 exhibits anti-inflammatory properties in microglia cells.
  • The anti-inflammatory effects of ENERGI-F704 are mediated through the AMPK signaling pathway.
  • ENERGI-F704 holds potential as a therapeutic agent for neuroinflammatory diseases.

Related Concept Videos